We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our
Privacy Policy
.
Yes, I accept
Menu
Corporate Members
E-Library
Twitter
Linked In
Facebook
Instagram
Join
MyESTRO
Search Opener
Search for:
About ESTRO
Membership
School
Workshops
Congresses
Science
Education
Advocacy
Corporate Members
E-Library
Home
Congresses
ESTRO 2026
Programme
Paediatric cancer
15 May 2026 - 19 May 2026
Stockholm, Sweden
ESTRO 2026
Session
Sunday
May 17
10:30 - 11:30
A3
Paediatric cancer
Co-Chair:
Emmanuel Jouglar
,
France
Session Type:
Proffered Papers
Track:
Clinical
Journey:
Add to
My Programme
10:30 - 11:30
Facial Structure Delineation in Paediatric Radiation Therapy: International Consensus Atlas to Support Dentofacial Side Effect Mitigation
Presenter
:
Lucy Siew Chen Davies
,
United Kingdom
Presentation Number:
-2712
10:30 - 11:30
Conventionally Fractionated Re-irradiation for Recurrent Pediatric Ependymoma: Long-term Results
Presenter
:
Thomas Merchant
,
USA
Presentation Number:
-4530
10:30 - 11:30
Survival outcomes of low-risk WNT-pathway medulloblastoma treated with de-escalated radiotherapy followed by adjuvant systemic chemotherapy
Presenter
:
Tejpal Gupta
,
India
Presentation Number:
-4510
10:30 - 11:30
Anlotinib Plus Radiotherapy for Newly Diagnosed Pediatric Malignant Brainstem Gliomas: Safety and Efficacy Evaluation
Presenter
:
Yuan-yuan Chen
,
China
Presentation Number:
-3738
10:30 - 11:30
Two decades of insight: key findings from a French retrospective multicenter analysis of pediatric localized intracranial ependymoma (NCT05151718)
Presenter
:
Anne Laprie
,
France
Presentation Number:
-821
10:30 - 11:30
Proton radiatiotherapy decreases radiation-associated second malignant neoplasms compared to photon radiatiotherapy in patients with retinoblastoma
Presenter
:
Sayeh Fattahi
,
USA
Presentation Number:
-2391
E-Mail Address
Please enter a user name
Password
Cancel
Forgotten Password
Create MyESTRO Account
i
Please log in to add this session to your programme.